This company is developing autologous neuron replacement therapy in sporadic Parkinson’s disease, and a gene-corrected autologous neuron replacement therapy for genetic variants that increase the risk of Parkinson’s disease. This means they would take skin cells from a patient, convert them into induced pluripotent stem cells (iPSCs) and then reprogram them into dopaminergic neurons, which are then transplanted into the brain.
Discover our Products
Science-based supplements that work synergistically
Sign Up to our Newsletter to get notified when the YuthLabs Red and Infrared Light Cap is live!
Subscribe & Join Our Pre-Order Waitlist
